Canadian pharmaceutical company Valeant Pharmaceuticals International, Inc. (NYSE:VRX) recently announced that it has raised its bid for ISTA Pharmaceuticals Inc. (NASDAQ:ISTA) to $7.50 from $6.50 per share in cash. Valeant Pharma also offered to increase the offer to $8.50 per share if ISTA offered it some confirmatory due diligence information. Valeant Pharma added that the offer remains valid till January 31, 2012.
Valeant Pharma made a hostile bid to acquire ISTA in December 2011 with an offer of … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards